Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups.

Overview of attention for article published in Journal of Clinical Oncology, May 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 2 news outlets
twitter: 71 X users
facebook: 1 Facebook page

f1000: 1 research highlight platform
guideline: 3 clinical guideline sources

Readers on

mendeley: 133 Mendeley

So far, Altmetric has seen 90 X posts from 71 X users, with an upper bound of 251,521 followers.

Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups https://t.co/kbO46U3x3s

RT @Finacruz2: Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 86 additional X posts.